Oncology Clinical Trials in Milwaukee, WI
As of September 2026, 163 paid clinical trials are recruiting for Oncology in Milwaukee, Wisconsin. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Milwaukee
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
164 clinical trials for Oncology
·Clear filters·Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
XTX301 in Patients With Advanced Solid Tumors
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Top Research Study Locations in Milwaukee
Researchers run research studies in Milwaukee, WI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Medical College of Wisconsin | Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Stroke | 248 |
| Aurora Sinai Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 50 |
| Aurora Saint Luke's Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 48 |
| Aurora Cancer Care-Milwaukee | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 46 |
| Children's Hospital of Wisconsin | B Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Malignant Solid Neoplasm | 42 |
| Froedtert & the Medical College of Wisconsin | Multiple Myeloma, Pancreatic Cancer, Refractory Multiple Myeloma | 23 |
| Children's Wisconsin | Abdominal Pain, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Refractory | 20 |
| Froedtert Hospital and the Medical College of Wisconsin | Central Nervous System Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL), Refractory Diffuse Large B Cell Lymphoma (DLBCL) | 19 |
| Froedtert Hospital & the Medical College of Wisconsin | Breast Cancer, Pancreas Cancer, Acute Myeloid Leukemia (AML) | 18 |
| Aurora St. Luke's Medical Center | Pulmonary Hypertension, Acute Decompensated Heart Failure, Acute Ischemic Stroke From Large Vessel Occlusion | 15 |
| Froedtert Hospital | Aortic Stenosis, Bladder Cancer, Breast Cancer | 15 |
| The Medical College of Wisconsin | Abdominal Wound Dehiscence, Acute Kidney Injury, Anal Fistula | 12 |
| Ascension Columbia Saint Mary's Hospital-Milwaukee Campus | Ampulla of Vater Carcinoma, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 10 |
| Froedtert & Medical College of Wisconsin | Cystic Fibrosis (CF), AML, Acute Myeloid Leukemia | 10 |
| Marquette University | Aging, Stroke, Aerobic Exercise | 8 |
| Zablocki Veterans Administration Medical Center | Stage IVA Prostate Cancer AJCC v8, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 7 |
| Froedtert and The Medical College of Wisconsin | Advanced Renal Cell Carcinoma (aRCC), Aggressive Variant Prostate Carcinoma, Clear Cell Renal Cell Carcinoma (ccRCC) | 6 |
| Ascension Columbia Saint Mary's Hospital - Milwaukee | Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Pancreatic Adenocarcinoma | 5 |
| Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee | Ampulla of Vater Carcinoma, Appendix Carcinoma, Carcinoma of Unknown Primary With Gastrointestinal Profile | 5 |
| Ascension Saint Francis Hospital-Milwaukee | Ampulla of Vater Carcinoma, Appendix Carcinoma, Carcinoma of Unknown Primary With Gastrointestinal Profile | 4 |
| Aurora St Luke's Medical Center | AMI, Cancer, Cutaneous Melanoma, Stage II | 4 |
| Clement J. Zablocki VA Medical Center, Milwaukee, WI | Atherosclerosis, De Novo Prostate Cancer, Lung Neoplasm | 4 |
| Medical College of Wisconsin/Children's Hospital of Wisconsin | Primary Immune Deficiency Disorder, Adenovirus, Covid19 | 4 |
| Advocate Aurora Research Institute | Cardiovascular Diseases, Functional Mitral Regurgitation, Heart Diseases | 3 |
| Ascension Saint Francis Hospital | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 3 |
Active & Upcoming Studies in Milwaukee (2026)
Recruiting trials in Milwaukee grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (268 active studies)
- FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma · Phase 1 · Medical College of Wisconsin
- Immunotherapy and Nodal-Sparing Irradiation for T-Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer · Phase 2 · Medical College of Wisconsin
Cardiovascular (49 active studies)
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study · Medical College of Wisconsin
- Fixed-Dose Combinations Pragmatic Randomized Implementation Trial for Blood Pressure Control · Brigham and Women's Hospital
Neurology & pain (34 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- Morphine or Ketamine for Analgesia · Phase 3 · Columbia University
Diabetes & metabolic (20 active studies)
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study · Medical College of Wisconsin
- Puerto Rican Obesity Intervention for Men · Medical College of Wisconsin
Pediatric (11 active studies)
- Amnioinfusion for Chorioamnionitis: Targeting Neonatal Brain Injury Biomarkers · Medical College of Wisconsin
- Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure · Medical College of Wisconsin
Mental health & behavior (5 active studies)
- My Path to Quit Tobacco · Phase 4 · University of Wisconsin, Madison
- Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers · Marquette University
HIV / STI (3 active studies)
- Screen Smart: Using Digital Health to Improve HIV Screening and Prevention · Children's Hospital Medical Center, Cincinnati
- Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV · Medical College of Wisconsin
Vaccines (1 active study)
Eye & vision (1 active study)
- Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease · Phase 2 · Alkeus Pharmaceuticals, Inc.
Common conditions studied in Milwaukee
- Acute Myeloid Leukemia (14 active studies)
- Breast Cancer (13 active studies)
- Heart Failure (13 active studies)
- Multiple Myeloma (11 active studies)
- Chronic Lymphocytic Leukemia (10 active studies)
- Follicular Lymphoma (10 active studies)
Leading research sponsors in Milwaukee
- Medical College of Wisconsin
- National Cancer Institute (NCI)
- AstraZeneca
- NRG Oncology
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Milwaukee?
There are approximately 665 recruiting clinical trials in Milwaukee, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Milwaukee pay participants?
Most recruiting trials in Milwaukee compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Milwaukee?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Milwaukee?
The most common conditions under active study in Milwaukee include Acute Myeloid Leukemia (14), Breast Cancer (13), Heart Failure (13), Multiple Myeloma (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Milwaukee?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Milwaukee on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Milwaukee?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Milwaukee?
Recruiting research sites in Milwaukee include Medical College of Wisconsin, Aurora Sinai Medical Center, Aurora Saint Luke's Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Milwaukee right now?
The largest active categories in Milwaukee are Cancer & tumors (268), Cardiovascular (49), Neurology & pain (34). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.